- Home
- NMTC vs PLUR Comparison
NMTC vs PLUR Comparison
Compare NMTC & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NMTC | PLUR |
|---|---|---|
| Founded | 2009 | 2001 |
| Country | United States | Israel |
| Employees | N/A | 142 |
| Industry | Medical/Dental Instruments | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.5M | 31.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NMTC | PLUR |
|---|---|---|
| Price | $0.79 | $3.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $2.23 | ★ $12.00 |
| AVG Volume (30 Days) | ★ 252.9K | 44.2K |
| Earning Date | 12-17-2025 | 02-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $12,097,692.00 | $1,326,000.00 |
| Revenue This Year | N/A | $97.38 |
| Revenue Next Year | $31.19 | $293.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 250.35 | 121.74 |
| 52 Week Low | $0.40 | $2.82 |
| 52 Week High | $1.39 | $7.13 |
Technical Indicators
Market Signals| Indicator | NMTC | PLUR |
|---|---|---|
| Relative Strength Index (RSI) | 62.85 | 46.60 |
| Support Level | $0.65 | $2.82 |
| Resistance Level | $0.83 | $3.72 |
| Average True Range (ATR) | 0.07 | 0.34 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 92.18 | 43.64 |
Price Performance
Historical ComparisonAbout NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.